Pharmacological treatment for antisocial personality disorder alcoholics: a preliminary study. 1996

E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
Department of Psychiatry, Kansas University Medical Center, Kansas City 66160-7341, USA.

A short time ago, we reported that a subgroup of hospitalized alcoholic men with comorbid antisocial personality disorder (ASP) seemed to benefit significantly from antidepressant medication at the end of a 6-month period in a double-blind, random assignment, placebo-controlled study. In a reanalysis of those data, we divided the ASP alcoholic group (n = 29) into those who did (n = 15) and who did not (n = 14) also satisfy DSM-III-R criteria for an additional current mood and/or anxiety disorder and then compared the 6-month outcomes of these two smaller subgroups. Despite the small ns, the results for most drinking outcome measures indicated: (1) that ASP alcoholics with a current mood/anxiety disorder improved significantly more with pharmacological treatment, relative to placebo; and (2) that ASP alcoholics with no current mood/anxiety disorder failed to respond differentially to pharmacological treatment over the 6-month period. These findings suggest a possibly useful and inexpensive approach to the long-term management of a very difficult-to-treat subgroup of men substance abusers.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009661 Nortriptyline A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. Desitriptyline,Desmethylamitriptylin,Allegron,Apo-Nortriptyline,Aventyl,Gen-Nortriptyline,Norfenazin,Nortrilen,Nortriptyline Hydrochloride,Novo-Nortriptyline,Nu-Nortriptyline,PMS-Nortriptyline,Pamelor,Paxtibi,ratio-Nortriptyline,Apo Nortriptyline,Gen Nortriptyline,Hydrochloride, Nortriptyline,Novo Nortriptyline,Nu Nortriptyline,PMS Nortriptyline,ratio Nortriptyline
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
August 2010, The Cochrane database of systematic reviews,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
September 2020, The Cochrane database of systematic reviews,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
November 2008, The British journal of psychiatry : the journal of mental science,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
May 1988, Journal of studies on alcohol,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
March 2023, Expert review of clinical pharmacology,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
November 2006, Psychiatry research,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
July 1993, Journal of psychiatry & neuroscience : JPN,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
January 2003, Ryoikibetsu shokogun shirizu,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
January 2016, Duodecim; laaketieteellinen aikakauskirja,
E C Penick, and B J Powell, and J Campbell, and B I Liskow, and E J Nickel, and T M Dale, and H M Thomas, and L J Laster, and E Noble
January 1992, Hospital & community psychiatry,
Copied contents to your clipboard!